On Wednesday, April 15, 2015, Judge Kimberly J Mueller of the US Court in Sacramento upheld the constitutionality of marijuana’s Schedule I designation in the 5-tier classification set down by Congress in 1970. Schedule I drugs must have a high potential for abuse.
On April 16, 2015, Governor Butch Otter of Idaho issued an executive order allowing for expanded access to Epidiolex, a pure, pharmacy version of cannabidiol (CBD). He vetoed a bill that would have allowed non-pharmacy grade CBD for the treatment of seizures.
Parents Opposed to Pot calls on the national media to clarify the distinction between cannabidiol (CBD) Continue reading Judge Upholds the Schedule I Classification
CNN’s Dr. Sanjay Gupta left the wrong impression on many Americans when discussing marijuana, which is why the media needs to stop saying medical marijuana when they mean cannabidiol or CBD. Marijuana is very different from cannabidiol, the marijuana derivative which Dr. Gupta advocates for treating some types of epilepsy in children.
The marijuana plant has more than 400 compounds, and at least 60 different cannabinoids which bind to receptors in our body. Cannabidiol is one of those 60 cannabinoids. Tetrahydrocannabinol or THC is a different cannabinoid, the main psychoactive component and the one responsible for the “high” of marijuana.
The medical marijuana advocates have intentionally confused the public about medical marijuana research at this time. Cannabidiol has been isolated by a company in Great Britain and is being fast-tracked for approval by the Food and Drug Administration (FDA). Continue reading Cannabidiol or CBD is not Same as Medical Marijuana